Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Nelson

Showing results (461-470 of 519) with videos related to

Pageof 52
Sort By:
Cancer Research|January 1, 1990
Immunomodulatory properties and toxicity of interleukin 2 in patients with cancerW J Urba, R G Steis, D L Longo, et al.
Human Molecular Genetics|March 1, 1997
Molecular and phenotypic variation in patients with severe Hunter syndromeK M Timms, M L Bondeson, M A Ansari-Lari, et al.
Journal of Clinical Microbiology|August 1, 1986
Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infectionD K Wagner, B S Graham, P F Wright, et al.
Human Molecular Genetics|April 1, 1993
Alternative splicing in the fragile X gene FMR1A J Verkerk, E de Graaff, K De Boulle, et al.
The American Review of Respiratory Disease|September 1, 1989
Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantationE C Lawrence, V A Holland, J B Young, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 8, 2006
Dichloro(4,10-dimethyl-1,4,7,10-tetraazabicyclo[5.5.2]tetradecane)iron(III) hexafluorophosphateJames M McClain, Danny L Maples, Randall D Maples, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivityM M Foreman, R W Fuller, K Rasmussen, et al.
American Journal of Medical Genetics|April 1, 1992
Intragenic probe used for diagnostics in fragile X familiesA J Verkerk, B B deVries, M F Niermeijer, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 1, 1994
Fragile X syndrome in a normal IQ male with learning and emotional problemsS A Merenstein, V Shyu, W E Sobesky, et al.
Human Molecular Genetics|October 9, 2001
A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutationsS Aradhya, H Woffendin, T Jakins, et al.
Pageof 52

Showing results (461-470 of 519) with videos related to

Sort By:
Pageof 52
Cancer Research|January 1, 1990
Immunomodulatory properties and toxicity of interleukin 2 in patients with cancerW J Urba, R G Steis, D L Longo, et al.
Human Molecular Genetics|March 1, 1997
Molecular and phenotypic variation in patients with severe Hunter syndromeK M Timms, M L Bondeson, M A Ansari-Lari, et al.
Journal of Clinical Microbiology|August 1, 1986
Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infectionD K Wagner, B S Graham, P F Wright, et al.
Human Molecular Genetics|April 1, 1993
Alternative splicing in the fragile X gene FMR1A J Verkerk, E de Graaff, K De Boulle, et al.
The American Review of Respiratory Disease|September 1, 1989
Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantationE C Lawrence, V A Holland, J B Young, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 8, 2006
Dichloro(4,10-dimethyl-1,4,7,10-tetraazabicyclo[5.5.2]tetradecane)iron(III) hexafluorophosphateJames M McClain, Danny L Maples, Randall D Maples, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivityM M Foreman, R W Fuller, K Rasmussen, et al.
American Journal of Medical Genetics|April 1, 1992
Intragenic probe used for diagnostics in fragile X familiesA J Verkerk, B B deVries, M F Niermeijer, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 1, 1994
Fragile X syndrome in a normal IQ male with learning and emotional problemsS A Merenstein, V Shyu, W E Sobesky, et al.
Human Molecular Genetics|October 9, 2001
A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutationsS Aradhya, H Woffendin, T Jakins, et al.
Pageof 52